News and Announcements
Proteomics Launch New Company Website and Corporate Video
- Published February 09, 2016 10:08AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
9th February 2016, ASX Announcement
Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to announce the launch of its new company website.
The website is available at: www.proteomics.com.au or www.proteomicsinternational.com.au
The new website replaces the previous business and corporate corporate websites in one comprehensive site designed to provide details of the company’s full range of services plus information for investors.
PILL is also pleased to present its new corporate video, which describes the Company’s ground-breaking predictive test for diabetic kidney disease. The video is accessible via the PromarkerD page ont he website.
To view the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
